Publication | Open Access
Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma
22
Citations
22
References
2020
Year
A high level of serum kynurenine correlated with poor prognosis of HCC. Serum kynurenine levels may be a novel biomarker to predict the prognosis of patients with HCC. The development of drugs that inhibit kynurenine production is expected to help improve the prognosis of patients with HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1